Andrew A. Hindman

Insider Reports History

Location
Ardsley, NY
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew A. Hindman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP, CHIEF FINANCIAL OFFICER Ordinary Shares 384,714 $3,958,707 $10.29 20 Nov 2022 Direct

Insider Reports Filed by Andrew A. Hindman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TBPH Theravance Biopharma, Inc. 18 Nov 2022 2 -$988,110 4 SVP, CHIEF FINANCIAL OFFICER 22 Nov 2022, 15:07
TBPH Theravance Biopharma, Inc. 19 Aug 2022 1 -$239,814 4 SVP, CHIEF FINANCIAL OFFICER 23 Aug 2022, 19:00
TBPH Theravance Biopharma, Inc. 25 Jul 2022 1 $0 4 SVP, CHIEF FINANCIAL OFFICER 27 Jul 2022, 18:56
TBPH Theravance Biopharma, Inc. 20 May 2022 1 -$29,410 4 SVP, CHIEF FINANCIAL OFFICER 24 May 2022, 19:17
TBPH Theravance Biopharma, Inc. 18 Feb 2022 1 -$249,601 4 SVP, CHIEF FINANCIAL OFFICER 23 Feb 2022, 17:29
TBPH Theravance Biopharma, Inc. 02 Dec 2021 1 $0 4 SVP, Chief Financial Officer 06 Dec 2021, 18:53
TBPH Theravance Biopharma, Inc. 19 Nov 2021 1 -$11,286 4 SVP, CHIEF FINANCIAL OFFICER 23 Nov 2021, 19:22
TBPH Theravance Biopharma, Inc. 20 Aug 2021 1 -$245,369 4 SVP, Chief Financial Officer 24 Aug 2021, 18:55
TBPH Theravance Biopharma, Inc. 20 May 2021 1 -$16,768 4 SVP, Chief Financial Officer 24 May 2021, 18:10